Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 961 - 980 results of 39,063 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 0.95s Refine Results
  1. 961
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 962
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 963
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 964
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 965
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 966
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 967
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 968
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 969
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 970
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 971
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 972
    Mean score and proportion of selected items among women gave birth in Hossana town administration, southern Ethiopia, 2018.

    Mean score and proportion of selected items among women gave birth in Hossana town administration, southern Ethiopia, 2018. by Getachew Ossabo Babore (10788843)

    Published 2021
    Save to List
    Saved in:
  13. 973
    During electrical stimulation the decrease in compound action potential (CAP), but not of ATP, is larger in <i>Plp</i><sup>null/y</sup> mice.

    During electrical stimulation the decrease in compound action potential (CAP), but not of ATP, is larger in <i>Plp</i><sup>null/y</sup> mice. by Andrea Trevisiol (9647910)

    Published 2020
    Save to List
    Saved in:
  14. 974
    Transient kinetic analysis of the S100A4-N-ERMAD interaction.

    Transient kinetic analysis of the S100A4-N-ERMAD interaction. by Beáta Biri-Kovács (4020650)

    Published 2017
    “…<p>(A, B) 2 μM N-ERMAD or F2 lobe (respectively) was mixed with an equal volume of S100A4 in different concentrations and a decrease in intrinsic Trp fluorescence was monitored over time (left panel). …”
    Save to List
    Saved in:
  15. 975
    Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line.

    Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line. by Benedikt B. Kaufer (341018)

    Published 2013
    Save to List
    Saved in:
  16. 976
    Box plot JRS, EQ-5D-5L, and NEI-VFQ-25 at each visit.

    Box plot JRS, EQ-5D-5L, and NEI-VFQ-25 at each visit. by Parima Hirunwiwatkul (14797370)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 977
    Table_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.DOCX

    Table_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.DOCX by Ji-Sook Lee (632672)

    Published 2020
    “…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”
    Save to List
    Saved in:
  18. 978
    Table_2_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.DOCX

    Table_2_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.DOCX by Ji-Sook Lee (632672)

    Published 2020
    “…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”
    Save to List
    Saved in:
  19. 979
    Presentation_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.PPT

    Presentation_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.PPT by Ji-Sook Lee (632672)

    Published 2020
    “…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”
    Save to List
    Saved in:
  20. 980
    Overexpression of PR decreases Myc expression and activity.

    Overexpression of PR decreases Myc expression and activity. by Tamar Kavlashvili (849072)

    Published 2016
    Save to List
    Saved in:

Search Tools: